Listen to the conversation as they discuss:

• How health equity is a key component of Thermo Fisher’s core business.
• How Thermo Fisher leverages its capabilities and customer relationships to further its impact.
• Initiatives that improve health equity through accessibility to drug-resistant HIV testing, next-generation sequencing to diagnose lung and breast cancer in 30 underserved countries, increasing the accessibility to and diversity in clinical trials, and more.
• New programs in 2024.